Alosetron Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C17H18N4O·HCI 330.82
1H-Pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-, hydrochloride; 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride CAS RN®: 122852-69-1.
1 DEFINITION
Alosetron Hydrochloride contains NLT 98.0% and NMT 102.0% of alosetron hydrochloride (C17H18N4O·HCI), calculated on the anhydrous basis.
2 IDENTIFICATION
Change to read:
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197A OR 197K (CN 1-MAY-2020) Meets the requirements
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
C. IDENTIFICATION TESTS-GENERAL (191), Chloride: Meets the requirements of the silver nitrate precipitation test
3 ASSAY
3.1 PROCEDURE
Protect solutions containing alosetron hydrochloride from light.
Buffer: 0.02 M monobasic sodium phosphate. Adjust with phosphoric acid to a pH of 3.0.
Mobile phase: Buffer and acetonitrile (80:20)
Standard solution: 0.05 mg/mL of USP Alosetron Hydrochloride RS in Mobile phase
Sample solution: 0.05 mg/mL of Alosetron Hydrochloride in Mobile phase
Chromatographic system
(See Chromatography (621), System Suitability.).
Mode: LC
Detector: UV 220 nm
Column: 4.6-mm × 7.5-cm; 3-µm packing L1
Flow rate: 1.0 mL/min
Injection volume: 5 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of alosetron hydrochloride (C17H18N4O·HCI) in the portion of Alosetron Hydrochloride taken:
Result = (rU/rS) x (CS/CU) x 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS =concentration of USP Alosetron Hydrochloride RS in the Standard solution (mg/mL)
CU = concentration of Alosetron Hydrochloride in the Sample solution (mg/mL)
Acceptance criteria: 98.0%-102.0% on the anhydrous basis
4 IMPURITIES
4.1 RESIDUE ON IGNITION (281)
NMT 0.2%
Change to read:
4.2 ORGANIC IMPURITIES
Protect solutions containing alosetron hydrochloride from light.
Buffer and Chromatographic system: Proceed as directed in the Assay.
Solution A: Buffer
Solution B: Acetonitrile
Mobile phase: See Table 1. Return to original conditions and re-equilibrate the system.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
| 0 | 90 | 10 |
| 5 | 90 | 10 |
| 20 | 50 | 50 |
| 25 | 50 | 50 |
Diluent: Buffer and acetonitrile (90:10)
System suitability solution: 0.5 mg/mL of USP Alosetron Hydrochloride RS and 0.5 µg/mL of USP Alosetron Related Compound A RS in Diluent
Standard solution: 0.5 µg/mL of USP Alosetron Hydrochloride RS in Diluent
Sensitivity solution: 0.25 µg/mL of USP Alosetron Hydrochloride RS in Diluent from the Standard solution
Sample solution: 500 µg/mL of Alosetron Hydrochloride in Diluent
System suitability
Samples: System suitability solution, Standard solution, and Sensitivity solution
Suitability requirements
Resolution: NLT 3 (ERR 1-May-2020) between alosetron and alosetron related compound A, System suitability solution
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each individual impurity in the portion of Alosetron Hydrochloride taken:
Result = (rU/rS) x (CS/CU) x (1/F) x 100
rU = peak response of each impurity from the Sample solution
rS = peak response of alosetron from the Standard solution
CS = concentration of USP Alosetron Hydrochloride RS in the Standard solution (µg/mL)
CU = concentration of Alosetron Hydrochloride in the Sample solution (µg/mL)
F = relative response factor (see Table 2)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Alosetron | 1.0 | — | — |
| Alosetron related compound A | 1.1 | 1.3 | 0.15 |
| Any other individual impurity | — | 1.0 | 0.10 |
| Total impurities | — | — | 0.8 |
5 SPECIFIC TESTS
WATER DETERMINATION (921), Method I, Method Ia: NMT 1.0%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in tight containers. Store between 15° and 30°, protected from light.
USP REFERENCE STANDARDS (11).
USP Alosetron Hydrochloride RS
USP Alosetron Related Compound A RS
Dealkyl alosetron;
5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one.
C12H12N2O 200.24

